Publications Database

Buchsbaum M. (2001)

Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study

International Journal of Neuropsycholpharmacology

4(2), pp. 119-125

Read Abstract (New Window)

Campbell M. et al. (1971)

Imipramine in preschool autistic and schizophrenic children.

Journal of Autism and Developmental Disorders

1(3), pp. 267-282.

Read Abstract (New Window)

Campbell M. , Cueva J. E. (1995)

Psychopharmacology in child and adolescent psychiatry: a review of the past seven years: Part 1

Journal of the American Academy of Child and Adolescent Psychiatry

34(9), pp. 1124-1132

Read Abstract (New Window)

Canitano R. , Scandurra V. (2011)

Psychopharmacology in autism: An update.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

35(1), pp. 18-28.

Read Abstract (New Window)

Carminati G. G. , Deriaz N. , Bertschy G. (2006)

Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms

Progress in Neuro-Psychopharmacology and Biological Psychiatry

30(2), pp. 312-315

Read Abstract (New Window)

Carrasco M. , Volkmar F. R. , Bloch M. H. (2012)

Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: Evidence of publication bias.

Pediatrics

129(5), e1301-e1310.

Read Abstract (New Window) Read Full (New Window)

NHS Choices (2006)

Antidepressants.

London: National Health Service

Read Full (New Window)

Consoli A. et al. (2010)

Lorazepam, fluoxetine and packing therapy in an adolescent with pervasive developmental disorder and catatonia.

Journal of Physiology Paris

104(6), pp. 309-314.

Read Abstract (New Window)

Coskun M. et al. (2009)

Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

19(2), pp. :203-206

Read Abstract (New Window)

Coskun M. , Mukaddes N. M. (2008)

Mirtazapine treatment in a subject with autistic disorder and fetishism

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 206-209

Read Abstract (New Window)

Coury D. (2011)

Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders.

Evidence Based Mental Health

May, 127(5),

Read Abstract (New Window) Read Full (New Window)

Coury D. et al. (2012)

Use of psychotropic medication in children and adolescents with autism spectrum disorders.

Pediatrics

130 S69-76.

Read Abstract (New Window) Read Extract (New Window)

Couturier J. . L. , Nicolson R. (1992)

A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

12(3), pp. 243-248

Read Abstract (New Window)

DeLong G. R. , Teague L. , McSwain K. M. (1998)

Effects of fluoxetine treatment in young children with idiopathic autism

Developmental Medicine and Child Neurology

40(8), pp. 551-562

Read Abstract (New Window)

Dinca O. , Paul M. , Spencer N. (2005)

Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorder.

Journal of Psychopharmacology

19(5), pp. 521-532

Read Abstract (New Window)

Dove D. et al. (2012)

Medications for adolescents and young adults with autism spectrum disorders: A systematic review.

Pediatrics

130(4), pp. 717 -726.

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Dialogues in Clinical Neuroscience

14(3), pp. 263-279.

Read Abstract (New Window) Read Full (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Earle J. F. (2016)

An introduction to the psychopharmacology of children and adolescents with autism spectrum disorder.

Journal of Child and Adolescent Psychiatric Nursing

May, 29(2), pp. 62-71.

Read Abstract (New Window)

Eissa N. et al.

Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder.

Frontiers in Neuroscience

Read Full (New Window)